Literature DB >> 30178425

Gender Differences in Ischemic Cardiomyopathy.

Laura Divoky1, Anbukarasi Maran1, Bhavadharini Ramu2.   

Abstract

PURPOSE OF REVIEW: Cardiovascular disease remains the leading cause of death among women globally, majority of which are due to ischemic heart disease. Despite the recent advances in the overall management of CVD, there are unique challenges in the diagnosis and management of women as well as poorer outcomes. RECENT
FINDINGS: Women with ischemic cardiomyopathy experience significant morbidity and mortality. Differences in underlying pathology, delays in presentation, diagnosis, and treatment as well as the under-representation of women in clinical trials contribute to these poor outcomes. In this review, we discuss the nuances of gender-specific differences in the burden, clinical presentation, and outcomes of ischemic cardiomyopathy in women, in addition to discussion of areas needing further research.

Entities:  

Keywords:  Coronary artery disease; Gender; Gender disparities; Heart failure; Ischemic cardiomyopathy; Women

Mesh:

Substances:

Year:  2018        PMID: 30178425     DOI: 10.1007/s11883-018-0750-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  129 in total

1.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

2.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

3.  Recent changes in cardiovascular risk factors among women and men.

Authors:  Jung Ki Kim; Dawn Alley; Teresa Seeman; Arun Karlamangla; Eileen Crimmins
Journal:  J Womens Health (Larchmt)       Date:  2006 Jul-Aug       Impact factor: 2.681

4.  Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Karol E Watson; Ana Barac; Theresa M Beckie; Vera Bittner; Salvador Cruz-Flores; Susan Dent; Lavanya Kondapalli; Bonnie Ky; Tochukwu Okwuosa; Ileana L Piña; Annabelle Santos Volgman
Journal:  Circulation       Date:  2018-02-01       Impact factor: 29.690

5.  Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.

Authors:  S C Wong; L A Sleeper; E S Monrad; M A Menegus; A Palazzo; V Dzavik; A Jacobs; X Jiang; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Authors:  James B Young; Mark E Dunlap; Marc A Pfeffer; Jeffrey L Probstfield; Alain Cohen-Solal; Rainer Dietz; Christopher B Granger; Jaromir Hradec; Jerzy Kuch; Robert S McKelvie; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Peter Held; Scott D Solomon; Salim Yusuf; Karl Swedberg
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

7.  Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator.

Authors:  Robert W Rho; Kristen K Patton; Jeanne E Poole; John G Cleland; Ramin Shadman; Inder Anand; Aldo Pietro Maggioni; Peter E Carson; Karl Swedberg; Wayne C Levy
Journal:  Circulation       Date:  2012-10-16       Impact factor: 29.690

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

10.  Gender differences in achieving optimal lipid goals in patients with coronary artery disease.

Authors:  Brett M Victor; Valerie Teal; Lilian Ahedor; Dean G Karalis
Journal:  Am J Cardiol       Date:  2014-03-01       Impact factor: 2.778

View more
  2 in total

1.  Estrogen negatively regulates the renal epithelial sodium channel (ENaC) by promoting Derlin-1 expression and AMPK activation.

Authors:  Xue Zhang; Yamei Ge; Ashfaq-Ahmad-Shah Bukhari; Qian Zhu; Yachen Shen; Min Li; Hui Sun; Dongming Su; Xiubin Liang
Journal:  Exp Mol Med       Date:  2019-05-21       Impact factor: 8.718

2.  Analysis of susceptibility genes and myocardial infarction risk correlation of ischemic cardiomyopathy based on bioinformatics.

Authors:  Nai Zhang; Chuang Yang; Yu-Juan Liu; Peng Zeng; Tao Gong; Lu Tao; Xin-Ai Li
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.